Home Latest Articles
Latest Articles
  • Qing XIAO, Lei-hong XIANG, Cheng-feng ZHANG
    World Clinical Drug. 2018, 39(7): 488-491.

    Hydrogen sulfide (H2S), the third endogenous gaseous signal molecule, is found after nitric oxide (NO) and carbon monoxide (CO). H2S is involved in many physiological and pathological processes of human body. It can clear reactive oxygen species (ROS), up-regulate antioxidant level and play a protective role when human organs and systems are under oxidative stress. H2S has a promising prospect in basic research and clinical application. This article describes the protective effect of H2S on oxidative stress.

  • Yan LIU, Hong-yu DENG
    World Clinical Drug. 2018, 39(7): 492-495.

    Schizophrenia is associated with a greater prevalence of health problems, including osteoporosis and bone fractures. Excessive bone mineral density (BMD) loss is related with schizophrenia itself,and may also with antipsychotic drugs and the drug that increases prolactin. It is also mixed with some bad habits. This review summarizes the risk of osteoporosis in schizophrenia patients and its related factors.

  • Zhe-wei WANG, Jing-yu SHAO
    World Clinical Drug. 2018, 39(7): 496-501.

    Estrogen is an important female hormone for the maintenance of women health and formatting menstruation cycle with progestin. Women need estrogen supplement in certain exceptional circumstances. However, there is some disagreement in the estrogen application of artificial cyclic treatment (ACT). This article introduces the estrogen application in ACT and its risk.

  • Hao LI, Fang-hong SHI, Zhi-chun GU, Xiao-yan LIU, Long SHEN
    World Clinical Drug. 2018, 39(7): 502-504.

    This article describes a screened list of the drugs, which can only be diluted with glucose injection. The approval numbers of drugs in China are counted and the relevant instructions according to the drug approval number are collected as well. A series of statistical analysis of the drug instructions labeled with 0.9% sodium chloride injection compatibility to insulin and its imcompatibity reasons, including the combinations with other drugs, the drug concentration in solution, the drop speed and labeling infusion time are described. This review provides a clinical medication reference to these drugs used for diabetics.

  • Gang ZHENG
    World Clinical Drug. 2018, 39(6): 361-364.

    Resistant hypertension (RH) is a highly risky disease, which needs accurate diagnosis and effective treatment. This article describes the clinical research progress of RH regarding pathogenesis, risk factors, diagnosis, prognosis and treatment.

  • Gang ZHENG
    World Clinical Drug. 2018, 39(6): 365-368.

    Hypertension is one of the major diseases caused to death in the world. At present, the reasonable level of blood pressure control is still controversial. Meanwhile, the drug adverse reactions and drug resistance are also important factors to affect the efficacy of antihypertensive drugs. This article reviews the recent clinical studies related to the hypertension drug therapy in a new understanding.

  • Gang ZHENG
    World Clinical Drug. 2018, 39(6): 369-373.

    The hypertension treatment in elderly is a very important clinical field. However, the control rates of elderly hypertension patients are still lower in the world. This article reviews the clinical research progress of elderly hypertension to provide the reference for its diagnosis and treatment.

  • Gang ZHENG
    World Clinical Drug. 2018, 39(6): 374-377.

    More and more evidences show that hypertension is the most important risk factor of cerebrovascular disease (CVD) including dementia and Alzheimer's disease. Generally, exercise is beneficial to the prevention from hypertension, cognitive impairment and CVD. This review describes the correlation of exercise with hypertension, cognitive impairment and CVD in detail.

  • Jing AI, Jian-hua CHEN, Sha-sha LU, Hui-qun PANG, Lan-ying HUANG
    World Clinical Drug. 2018, 39(6): 378-383.
    Objective

    To explore the effect of antihypertensive massage exercise on clinical symptoms, blood pressure and life quality in the patients with primary hypertension.

    Methods

    A total of 160 patients with primary hypertension, who met the inclusion criteria were selected and randomly divided into treatment group and control group as 80 cases each group. The control group maintained the original antihypertensive drugs, and the treatment group additionally took the antihypertensive massage exercise on the basis of original antihypertensive therapy. The blood pressure (systolic and diastolic pressure) before intervention and after 30 d and 60 d intervention and the clinical symptom score before intervention and after 60 d intervention of two groups were recorded. The antihypertensive effect and the effect of improving traditional Chinese medicine clinical symptom were evaluated. The life quality in two groups was evaluated through hypertension quality of life scale.

    Results

    The blood pressure of treatment group after 30 d intervention was lower than that before intervention (P<0.01), and the blood pressure of the control group had no significant change (P>0.05); the blood pressure after 60 d intervention was lower than before intervention in two groups (P<0.01); the total effective rate of antihypertensive therapy in the treatment group (78.75%) was higher than that of the control group (17.50%, P<0.01). After 60 d intervention, the clinical symptom scores of two groups were lower than those before intervention (P<0.01), and the total effective rate (85.00%) of the clinical symptom of treatment group was higher than that of the control group (51.25%, P<0.01). The physiological symptoms and somatization symptoms after 60 d intervention in the treatment group were improved than before intervention (P<0.05), but there was no significant difference in the quality of life of the control group before and after intervention (P>0.05).

    Conclusion

    The antihypertensive massage exercise is effective on the prevention, treatment and rehabilitation of hypertensive patients.

  • Min CAO, Li ZHOU, You-hua WANG, Duan ZHOU, Guang-hao LI, Su-yun YUAN
    World Clinical Drug. 2018, 39(6): 384-388.
    Objective

    To observe cardiac function and inflammatory cytokines in the patients with chronic heart failure (CHF) who were treated with Shenge powder.

    Methods

    All 96 cases with CHF were collected from January 2017 to December 2017 in Longhua hospital affiliated to Shanghai university of traditional Chinese medicine. These patients were randomly divided into treatment group (Shenge poweder and western medicine) and control group (western medicine) as 48 cases each group. All patients were treated continuously for 8 weeks. The cardiac index (CI), cardiac output (CO), ejection fraction (EF) and 6 minutes walking test (6MWT) were observed before and after treatment, and the plasma levels of BNP, CRP, IL-6, IL-10, TNF-α were also tested.

    Results

    After the treatment, the EF, CO, CI, 6MWT and the plasma levels of BNP, CRP, IL-6, IL-10 and TNF-α in both groups were improved significantly (P<0.05, P<0.01). Compared with control group, the EF, CO and 6MWT after treatment in treatment group were increased significantly (P<0.05), and the plasma levels of BNP and CRP, IL-6, TNF-α were decreased (P < 0.05, P < 0.01).

    Conclusion

    Shenge powder has certain efficacy on CHF, which may be related to its regulation of inflammatory cytokines and improvement of cardiac function.

News